Two studies find resistance mechanisms in ALK+ and ROS1+ cancers
Targeted treatments have revolutionized care for lung cancer patients whose tumors harbor ALK or ROS1 alterations. Basically, cancers may use these genetic changes to drive their growth, but also become dependent on the action ...
Apr 11, 2018
0
25